RxDoctor Payments Data

Michael Smith

Pediatric Infectious Diseases · Louisville, KYNPI 1336340454

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,600 of the $5,321 with a category attached, or 67.7%. Every reported general payment came from a single manufacturer, Merck. 2025 is the largest year on record at $1,721, 2.9 times the $600 reported in 2019.

$5,321in general payments, 2019–2025

Across 14 payments — averaging $380.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$5K
$1,111,928in research payments, 2019–2025

Across 134 payments — averaging $8297.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$830K
  • Merck$166K
  • Tetraphase Pharmaceuticals, Inc.$105K
  • Sanofi Pasteur Inc.$8K
  • Modernatx, Inc.$3K

What the payments were for

  • Consulting fees$3,60068%
  • Travel & lodging$1,39226%
  • Food & beverage$3306%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck14$5,321

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric infectious diseases providers in Kentuckyto place this figure against a meaningful peer group, so we don't.

Other pediatric infectious diseases in Louisville

Where these figures come from

Is this you, or does something look wrong? →